Using existing FDA-approved drugs to treat osteoarthritis
Repurposing FDA-approved drugs for the treatment of osteoarthritis using high-throughput screening in microphysiological models
This study is looking for new ways to use safe, already-approved medications to help people with osteoarthritis not just feel better, but actually improve their condition by targeting specific causes of the disease.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pittsburgh at Pittsburgh NIH-funded |
| Lab location | 1 site (Pittsburgh, United States) |
| Project ID | NIH-10940755 on NIH RePORTER |
What this research studies
This research focuses on finding new uses for FDA-approved drugs to treat osteoarthritis (OA), a painful joint condition affecting millions. By utilizing high-throughput screening in advanced human-like models, the study aims to identify effective treatments that can modify the disease rather than just relieve symptoms. The approach targets specific OA endotypes, which are different biological pathways involved in the disease, to enhance the chances of successful outcomes. This method is advantageous as it leverages existing drugs with known safety profiles, potentially speeding up the treatment development process.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with osteoarthritis, particularly those experiencing significant pain and mobility issues.
Not a fit: Patients with osteoarthritis who have already exhausted all FDA-approved treatment options or those with other unrelated joint disorders may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new, effective treatments that not only alleviate pain but also slow or reverse the progression of osteoarthritis.
How similar studies have performed: Previous research has shown promise in repurposing existing drugs for various conditions, indicating that this approach could be effective for osteoarthritis as well.
Where this research is happening
Pittsburgh, United States
- University of Pittsburgh at Pittsburgh — Pittsburgh, United States (Active)
Researchers
- Principal investigator: Lin, Hang — University of Pittsburgh at Pittsburgh
- Study coordinator: Lin, Hang
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.